Cilengitide |
αvβ3 and αvβ5 integrin inhibitor |
Enzastaurin (LY317615) |
Anti-angiogenic; protein kinase C inhibitor |
MK-2206 |
Akt inhibitor |
IL13-PE38QQR |
Cytotoxic to Interleukin-13–expressing cells |
Nimotuzumab |
EGFR inhibitor |
Cetuximab |
EGFR inhibitor |
MK-0752 |
Gamma secretase inhibitor |
RO4929097 |
Gamma secretase inhibitor |
Valproic acid |
Histone deacetylase inhibitor |
Vorinostat |
Histone deacetylase inhibitor |
LDE225 |
Inhibitor of the Smoothened G-protein–coupled receptor |
ABT-888 |
Poly(ADP-ribose) polymerase inhibitor |
Dendritic cells |
Vaccine |
Bevacizumab |
VEGF inhibitor |
Cediranib (AZD2171) |
VEGF receptor tyrosine kinase inhibitor |